These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10071705)

  • 1. Newer antipsychotics in treatment-resistant schizophrenia.
    Marder SR
    Biol Psychiatry; 1999 Feb; 45(4):383-4. PubMed ID: 10071705
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: how the doctor can counter commercial bias in the dissemination of pharmacotherapeutic knowledge.
    Carpenter WT
    J Nerv Ment Dis; 2002 Sep; 190(9):593-6. PubMed ID: 12357092
    [No Abstract]   [Full Text] [Related]  

  • 3. Methodological concerns in a trial of ziprasidone and olanzapine.
    Ross DE
    Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction: evaluating clinical trial data from schizophrenia research.
    Tamminga CA
    J Clin Psychiatry; 2001; 62 Suppl 9():3-4. PubMed ID: 11379829
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of schizophrenia drugs often favors firm funding study.
    Vendantam S
    Washington Post; 2006 Apr; ():A1, A6. PubMed ID: 16856276
    [No Abstract]   [Full Text] [Related]  

  • 7. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.
    Heres S; Davis J; Maino K; Jetzinger E; Kissling W; Leucht S
    Am J Psychiatry; 2006 Feb; 163(2):185-94. PubMed ID: 16449469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication removal and research in psychotic disorders.
    Baldessarini RJ; Viguera AC
    Arch Gen Psychiatry; 1998 Mar; 55(3):281-3. PubMed ID: 9510227
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine on trial.
    Capehart BP; Holsinger T
    Am J Psychiatry; 1998 Jan; 155(1):152; author reply 153-5. PubMed ID: 9433357
    [No Abstract]   [Full Text] [Related]  

  • 11. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
    Montgomery JH; Byerly M; Carmody T; Li B; Miller DR; Varghese F; Holland R
    Control Clin Trials; 2004 Dec; 25(6):598-612. PubMed ID: 15588746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia therapy: beyond atypical antipsychotics.
    Snyder EM; Murphy MR
    Nat Rev Drug Discov; 2008 Jun; 7(6):471-2. PubMed ID: 18483482
    [No Abstract]   [Full Text] [Related]  

  • 13. The statistical comparison of clinical trials.
    Schooler NR
    J Clin Psychiatry; 2001; 62 Suppl 9():35-7; discussion 38-9. PubMed ID: 11379830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-free research with schizophrenic patients. A European perspective.
    Henn FA; Lader M
    Arch Gen Psychiatry; 1997 May; 54(5):412-3. PubMed ID: 9152093
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence-based pharmacotherapy of schizophrenia.
    Emsley R; Oosthuizen P
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):219-38. PubMed ID: 15043765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis and hypothesis testing in the clinical trial.
    Lieberman JA
    J Clin Psychiatry; 2001; 62 Suppl 9():5-8; discussion 9-10. PubMed ID: 11379832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of first-episode schizophrenia.
    Rosenheck RA
    Lancet; 2008 Mar; 371(9618):1048-9. PubMed ID: 18374824
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical antipsychotics and cognition in schizophrenia.
    Sharma T
    Arch Gen Psychiatry; 2002 Jun; 59(6):571-2; author reply 573-5. PubMed ID: 12044209
    [No Abstract]   [Full Text] [Related]  

  • 20. Risperidone and clozapine for treatment-resistant schizophrenia.
    Meltzer HY
    Am J Psychiatry; 1999 Jul; 156(7):1126-7; author reply 1127-8. PubMed ID: 10401484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.